Importantly, the context-dependent effects of metformin, including its reduced benefit in APOE-4 carriers and potential risks in non-DM2 populations, emphasize the need for stratified patient selection when considering DM2 DMTs for AD prevention
1 Participants taking semaglutide 2.4 mg had a 20% reduction in major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal heart attack, and non-fatal stroke, compared to placebo
Lilly, too, has an amylin analog, eloralintide, in its portfolio
Learn more by reviewing our full editorial policy
MicrobiomeX is a patented citrus polyphenol prebiotic ingredient derived from orange and grapefruit fruit extracts
Your clinician may recommend increasing to the maximum licensed dose if you're tolerating the current dose well